医用画像試薬の世界市場レポート 2025年

医用画像試薬市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は6.9％で、213億1,000万米ドルに成長します。予測期間の成長は、個別化医療、疾病の早期発見への注目の高まり、慢性疾患の世界の負担増、ポイントオブケアイメージングの拡大、セラノスティクスの統合などに起因すると考えられます。予測期間の主な動向には、技術の進歩、慢性疾患の有病率の増加、個別化医療における画像診断、新興市場および世界の拡大、パートナーシップおよびコラボレーションなどが含まれます。

医用画像試薬市場の成長は、慢性疾患の増加によって促進されると予測されます。慢性疾患は、1年以上持続し、継続的な医学的治療が必要であることが特徴であるため、正確な診断と発見のために医用画像試薬を使用する必要があります。注目すべきは、2022年に米国がん協会が報告した、米国における推定190万人の新規がん患者と60万9360人のがん関連死亡者です。さらに、IDF Diabetes Atlas Tenth Edition 2021は、2021年に20歳から79歳の5億3,700万人が糖尿病に罹患していることを明らかにし、この数字は2030年までに6億4,300万人、2045年までに7億8,300万人に増加すると予測しています。この慢性疾患の急増が医用画像試薬市場成長の原動力となっています。

医用画像試薬市場もまた、製薬業界における需要の増加によって成長を目の当たりにすることになります。研究、医薬品開発、精密医療において重要な役割を果たす医用画像試薬は、製薬業界の発展に大きく貢献しています。例えば、欧州製薬団体連合会（EFPIA）は、2022年の欧州における医薬品生産総額は3,842億米ドル（3,400億ユーロ）で、前年比4.95％増と報告しています。このような製薬業界における需要の高まりが、医用画像試薬市場の成長を後押しする重要な要因となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界医用画像試薬PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、制約）
• 最終用途産業の分析
• 世界の医用画像試薬市場：成長率分析
• 世界の医用画像試薬市場の実績：規模と成長, 2019-2024
• 世界の医用画像試薬市場の予測：規模と成長, 2024-2029, 2034F
• 世界医用画像試薬総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の医用画像試薬市場：クラス別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 造影剤
• 光学試薬
• 核試薬
• 世界の医用画像試薬市場：技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ナノ粒子
• 蛍光染料
• プローブ放射性医薬品
• 蛍光タンパク質
• 量子ドット
• 世界の医用画像試薬市場：モダリティ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• X線
• CTスキャン
• 超音波
• MRIスキャン
• 世界の医用画像試薬市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 神経疾患
• 心血管疾患
• がん
• 胃腸障害
• 筋骨格障害
• 腎臓疾患
• その他の用途
• 世界の医用画像試薬市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• バイオテクノロジー企業
• 製薬会社
• 診断ラボ
• 世界の医用画像試薬市場、造影剤の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ヨウ素系造影剤
• 硫酸バリウム造影剤
• ガドリニウム造影剤
• 世界の医用画像試薬市場、光学試薬の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 蛍光染料
• 発光剤
• 光プローブ
• 世界の医用画像試薬市場核試薬の種類別の細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
• 放射性同位元素
• 放射性医薬品

第7章 地域別・国別分析

• 世界の医用画像試薬市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の医用画像試薬市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 医用画像試薬市場：競合情勢
• 医用画像試薬市場：企業プロファイル
  • General Electric Company Overview, Products and Services, Strategy and Financial Analysis
  • Lantheus Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Bracco SpA Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Siemens AG
• PerkinElmer Inc.
• Cardinal Health Inc.
• Shimadzu Corporation
• Philips Healthcare
• SA Laboratoires Andre Guerbet
• Canon Medical Systems Corporation
• Fujifilm Healthcare
• Guerbet Group
• Merck KGaA
• Esaote SpA
• Hitachi Ltd.
• Koninklijke Philips N.V.
• Toshiba Corporation
• Hologic Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 医用画像試薬市場2029：新たな機会を提供する国
• 医用画像試薬市場2029：新たな機会を提供するセグメント
• 医用画像試薬市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Medical imaging reagents are substances utilized by medical practitioners and researchers to enhance the visibility of structures and organs, aiding in the identification, diagnosis, and treatment of diseases. They play a crucial role in visualizing structures or organs, allowing clinicians to improve disease identification and diagnosis.

The main classes of medical imaging reagents include contrast reagents, optical reagents, and nuclear reagents. Contrast agents specifically enhance radiodensity and increase the contrast of structures or fluids in medical imaging by altering the way electromagnetic radiation or ultrasound waves pass through the body. Various technologies involved in these reagents include nanoparticles, fluorescent dyes, radiopharmaceuticals, fluorescent proteins, and quantum dots. These technologies are applied in various imaging modes such as X-ray, CT scan, ultrasound, and MRI scan. Medical imaging reagents find applications in diverse medical conditions, including neurological disorders, cardiovascular disorders, cancer, gastrointestinal disorders, musculoskeletal disorders, nephrological disorders, and others. These reagents are used by various end-users, including biotechnology companies, pharmaceutical companies, and diagnostic labs.

The medical imaging reagents market research report is one of a series of new reports from The Business Research Company that provides medical imaging reagents market statistics, including medical imaging reagents industry global market size, regional shares, competitors with a medical imaging reagents market share, detailed medical imaging reagents market segments, market trends and opportunities, and any further data you may need to thrive in the medical imaging reagents industry. This medical imaging reagents market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The medical imaging reagents market size has grown strongly in recent years. It will grow from $15.23 billion in 2024 to $16.31 billion in 2025 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to increasing prevalence of diseases, growing aging population, expanding applications, regulatory approvals, strategic collaborations and partnerships.

The medical imaging reagents market size is expected to see strong growth in the next few years. It will grow to $21.31 billion in 2029 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to personalized medicine, increasing focus on early disease detection, rising global burden of chronic diseases, expanding point-of-care imaging, integration of theranostics. Major trends in the forecast period include technological advancements, increasing prevalence of chronic diseases, diagnostic imaging in personalized medicine, emerging markets and global expansion, partnerships and collaborations.

The growth of the medical imaging reagents market is anticipated to be propelled by the increasing prevalence of chronic diseases. Chronic diseases, characterized by lasting one year or longer and requiring ongoing medical attention, necessitate the use of medical imaging reagents for accurate diagnosis and detection. Notably, in 2022, the American Cancer Society reported an estimated 1.9 million new cancer cases and 609,360 cancer-related deaths in the United States. Additionally, the IDF Diabetes Atlas Tenth Edition 2021 revealed that 537 million individuals aged 20 to 79 years had diabetes in 2021, a figure expected to rise to 643 million by 2030 and 783 million by 2045. This surge in chronic diseases is a driving force behind the growth of the medical imaging reagents market.

The medical imaging reagents market is also set to witness growth due to the increasing demand in the pharmaceutical industry. Playing a crucial role in research, drug development, and precision medicine, medical imaging reagents contribute significantly to advancing pharmaceutical endeavors. For instance, the European Federation of Pharmaceutical Industries and Associations (EFPIA) reported a total pharmaceutical production of $384,200 million (€340,000 million) in Europe in 2022, reflecting a 4.95% increase from the previous year. This heightened demand in pharmaceutical industries is a key factor fueling the growth of the medical imaging reagents market.

A prominent trend in the medical imaging reagents market is the emphasis on product innovations by major companies to maintain their competitive positions. Notably, Aptamer Group plc, a UK-based company, introduced Optimer-Fc in March 2023. Optimer-Fc combines an Optimer binder with an antibody's Fc domain, enabling its use in IHC applications. This innovative reagent facilitates enhanced research, diagnostics, and forensics, offering improved precision and selectivity in detection.

Leading companies in the medical imaging reagents market are concentrating on creating innovative products, such as the cell painting kit, to boost their revenues. This kit features pre-optimized, verified fluorescent probes along with a compatible diluent, designed to streamline the cell painting workflow while ensuring excellent repeatability and validation for use in high-content screening systems. For example, in December 2023, Amazon Web Services (AWS), a US-based company, is revolutionizing drug discovery through high-throughput Cell Painting, an advanced image-based assay for high-content screening. This method enhances the understanding of cellular behaviors and phenotypes. By leveraging AWS's scalable infrastructure, researchers can effectively manage large volumes of cell image data and execute complex image processing tasks. The Cell Painting Batch solution on AWS, utilizing tools like CellProfiler, automates these processes and addresses challenges such as fluctuating workloads, collaboration hurdles, and high computational requirements. This approach accelerates drug discovery while also improving scientific reproducibility and fostering collaboration across laboratories.

In December 2023, Mindray, a multinational medical technology company based in China that specializes in developing and manufacturing medical equipment and accessories, acquired DiaSys Diagnostic Systems GmbH for an undisclosed amount. This acquisition enhances Mindray's global supply chain and broadens its in-vitro diagnostics (IVD) business. DiaSys Diagnostic Systems GmbH, located in Germany, focuses on creating diagnostic system solutions, including automated clinical chemistry analyzers, semi-automated analyzers, and point-of-care instruments.

Major companies operating in the medical imaging reagents market include General Electric Company, Lantheus Holdings Inc., Thermo Fisher Scientific Inc., Bayer AG, Bracco SpA, Siemens AG, PerkinElmer Inc., Cardinal Health Inc., Shimadzu Corporation, Philips Healthcare, SA Laboratoires Andre Guerbet, Canon Medical Systems Corporation, Fujifilm Healthcare, Guerbet Group, Merck KGaA, Esaote SpA, Hitachi Ltd., Koninklijke Philips N.V., Toshiba Corporation, Hologic Inc., Carestream Health Inc., Curium Pharma, Nordion Inc., IBA Molecular, Eckert & Ziegler Radiopharma GmbH, Advanced Accelerator Applications, Jubilant Life Sciences Limited, Mallinckrodt Pharmaceuticals, Nihon Kohden Corporation, Mindray Medical International Limited, Samsung Medison Co. Ltd., Analogic Corporation

North America was the largest region in the medical imaging reagents market in 2024. The regions covered in the medical imaging reagents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the medical imaging reagents market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The medical imaging reagents market consists of sales of fluorescent visualizing reagents, supermolecules, and magnetic resonance imaging reagents. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Medical Imaging Reagents Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on medical imaging reagents market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for medical imaging reagents ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The medical imaging reagents market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Class: Contrast Reagents; Optical Reagents; Nuclear Reagents
• 2) By Technology: Nanoparticles; Fluorescent Dyes; Probes Radiopharmaceuticals; Fluorescent Proteins; Quantum Dots
• 3) By Modality: X-ray; CT Scan; Ultrasound; MRI Scan
• 4) By Application: Neurological Disorder; Cardiovascular Disorder; Cancer; Gastrointestinal Disorder; Musculoskeletal Disorder; Nephrological Disorder; Other Applications
• 5) By End User: Biotechnology Companies; Pharmaceutical Companies; Diagnostic Labs
• Subsegments:
• 1) By Contrast Reagents: Iodine-Based Contrast Agents; Barium Sulfate Contrast Agents; Gadolinium-Based Contrast Agents
• 2) By Optical Reagents: Fluorescent Dyes; Luminescent Agents; Optical Probes
• 3) By Nuclear Reagents: Radioisotopes; Radiopharmaceuticals
• Companies Mentioned: General Electric Company; Lantheus Holdings Inc.; Thermo Fisher Scientific Inc.; Bayer AG; Bracco SpA
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Medical Imaging Reagents Market Characteristics

3. Medical Imaging Reagents Market Trends And Strategies

4. Medical Imaging Reagents Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Medical Imaging Reagents Growth Analysis And Strategic Analysis Framework

• 5.1. Global Medical Imaging Reagents PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Medical Imaging Reagents Market Growth Rate Analysis
• 5.4. Global Medical Imaging Reagents Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Medical Imaging Reagents Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Medical Imaging Reagents Total Addressable Market (TAM)

6. Medical Imaging Reagents Market Segmentation

• 6.1. Global Medical Imaging Reagents Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Contrast Reagents
• Optical Reagents
• Nuclear Reagents
• 6.2. Global Medical Imaging Reagents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Nanoparticles
• Fluorescent Dyes
• Probes Radiopharmaceuticals
• Fluorescent Proteins
• Quantum Dots
• 6.3. Global Medical Imaging Reagents Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• X-ray
• CT Scan
• Ultrasound
• MRI Scan
• 6.4. Global Medical Imaging Reagents Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Neurological Disorder
• Cardiovascular Disorder
• Cancer
• Gastrointestinal Disorder
• Musculoskeletal Disorder
• Nephrological Disorder
• Other Applications
• 6.5. Global Medical Imaging Reagents Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Biotechnology Companies
• Pharmaceutical Companies
• Diagnostic Labs
• 6.6. Global Medical Imaging Reagents Market, Sub-Segmentation Of Contrast Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Iodine-Based Contrast Agents
• Barium Sulfate Contrast Agents
• Gadolinium-Based Contrast Agents
• 6.7. Global Medical Imaging Reagents Market, Sub-Segmentation Of Optical Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Fluorescent Dyes
• Luminescent Agents
• Optical Probes
• 6.8. Global Medical Imaging Reagents Market, Sub-Segmentation Of Nuclear Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Radioisotopes
• Radiopharmaceuticals

7. Medical Imaging Reagents Market Regional And Country Analysis

• 7.1. Global Medical Imaging Reagents Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Medical Imaging Reagents Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Medical Imaging Reagents Market

• 8.1. Asia-Pacific Medical Imaging Reagents Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Medical Imaging Reagents Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Medical Imaging Reagents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Medical Imaging Reagents Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Medical Imaging Reagents Market

• 9.1. China Medical Imaging Reagents Market Overview
• 9.2. China Medical Imaging Reagents Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Medical Imaging Reagents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Medical Imaging Reagents Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Medical Imaging Reagents Market

• 10.1. India Medical Imaging Reagents Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Medical Imaging Reagents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Medical Imaging Reagents Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Medical Imaging Reagents Market

• 11.1. Japan Medical Imaging Reagents Market Overview
• 11.2. Japan Medical Imaging Reagents Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Medical Imaging Reagents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Medical Imaging Reagents Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Medical Imaging Reagents Market

• 12.1. Australia Medical Imaging Reagents Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Medical Imaging Reagents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Medical Imaging Reagents Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Medical Imaging Reagents Market

• 13.1. Indonesia Medical Imaging Reagents Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Medical Imaging Reagents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Medical Imaging Reagents Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Medical Imaging Reagents Market

• 14.1. South Korea Medical Imaging Reagents Market Overview
• 14.2. South Korea Medical Imaging Reagents Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Medical Imaging Reagents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Medical Imaging Reagents Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Medical Imaging Reagents Market

• 15.1. Western Europe Medical Imaging Reagents Market Overview
• 15.2. Western Europe Medical Imaging Reagents Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Medical Imaging Reagents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Medical Imaging Reagents Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Medical Imaging Reagents Market

• 16.1. UK Medical Imaging Reagents Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Medical Imaging Reagents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Medical Imaging Reagents Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Medical Imaging Reagents Market

• 17.1. Germany Medical Imaging Reagents Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Medical Imaging Reagents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Medical Imaging Reagents Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Medical Imaging Reagents Market

• 18.1. France Medical Imaging Reagents Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Medical Imaging Reagents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Medical Imaging Reagents Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Medical Imaging Reagents Market

• 19.1. Italy Medical Imaging Reagents Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Medical Imaging Reagents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Medical Imaging Reagents Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Medical Imaging Reagents Market

• 20.1. Spain Medical Imaging Reagents Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Medical Imaging Reagents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Medical Imaging Reagents Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Medical Imaging Reagents Market

• 21.1. Eastern Europe Medical Imaging Reagents Market Overview
• 21.2. Eastern Europe Medical Imaging Reagents Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Medical Imaging Reagents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Medical Imaging Reagents Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Medical Imaging Reagents Market

• 22.1. Russia Medical Imaging Reagents Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Medical Imaging Reagents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Medical Imaging Reagents Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Medical Imaging Reagents Market

• 23.1. North America Medical Imaging Reagents Market Overview
• 23.2. North America Medical Imaging Reagents Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Medical Imaging Reagents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Medical Imaging Reagents Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Medical Imaging Reagents Market

• 24.1. USA Medical Imaging Reagents Market Overview
• 24.2. USA Medical Imaging Reagents Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Medical Imaging Reagents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Medical Imaging Reagents Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Medical Imaging Reagents Market

• 25.1. Canada Medical Imaging Reagents Market Overview
• 25.2. Canada Medical Imaging Reagents Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Medical Imaging Reagents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Medical Imaging Reagents Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Medical Imaging Reagents Market

• 26.1. South America Medical Imaging Reagents Market Overview
• 26.2. South America Medical Imaging Reagents Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Medical Imaging Reagents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Medical Imaging Reagents Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Medical Imaging Reagents Market

• 27.1. Brazil Medical Imaging Reagents Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Medical Imaging Reagents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Medical Imaging Reagents Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Medical Imaging Reagents Market

• 28.1. Middle East Medical Imaging Reagents Market Overview
• 28.2. Middle East Medical Imaging Reagents Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Medical Imaging Reagents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Medical Imaging Reagents Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Medical Imaging Reagents Market

• 29.1. Africa Medical Imaging Reagents Market Overview
• 29.2. Africa Medical Imaging Reagents Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Medical Imaging Reagents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Medical Imaging Reagents Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Medical Imaging Reagents Market Competitive Landscape And Company Profiles

• 30.1. Medical Imaging Reagents Market Competitive Landscape
• 30.2. Medical Imaging Reagents Market Company Profiles
  • 30.2.1. General Electric Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Lantheus Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bracco SpA Overview, Products and Services, Strategy and Financial Analysis

31. Medical Imaging Reagents Market Other Major And Innovative Companies

• 31.1. Siemens AG
• 31.2. PerkinElmer Inc.
• 31.3. Cardinal Health Inc.
• 31.4. Shimadzu Corporation
• 31.5. Philips Healthcare
• 31.6. SA Laboratoires Andre Guerbet
• 31.7. Canon Medical Systems Corporation
• 31.8. Fujifilm Healthcare
• 31.9. Guerbet Group
• 31.10. Merck KGaA
• 31.11. Esaote SpA
• 31.12. Hitachi Ltd.
• 31.13. Koninklijke Philips N.V.
• 31.14. Toshiba Corporation
• 31.15. Hologic Inc.

32. Global Medical Imaging Reagents Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Medical Imaging Reagents Market

34. Recent Developments In The Medical Imaging Reagents Market

35. Medical Imaging Reagents Market High Potential Countries, Segments and Strategies

• 35.1 Medical Imaging Reagents Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Medical Imaging Reagents Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Medical Imaging Reagents Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer